Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

AIDS denialism and public health practice.

Chigwedere P, Essex M.

AIDS Behav. 2010 Apr;14(2):237-47. doi: 10.1007/s10461-009-9654-7. Review.

PMID:
20058063
2.

Estimating the lost benefits of antiretroviral drug use in South Africa.

Chigwedere P, Seage GR 3rd, Gruskin S, Lee TH, Essex M.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):410-5.

PMID:
19186354
3.

Efficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: a meta-analysis of published clinical trials.

Chigwedere P, Seage GR, Lee TH, Essex M.

AIDS Res Hum Retroviruses. 2008 Jun;24(6):827-37. doi: 10.1089/aid.2007.0291.

PMID:
18544018
4.

Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?

Novitsky V, Smith UR, Gilbert P, McLane MF, Chigwedere P, Williamson C, Ndung'u T, Klein I, Chang SY, Peter T, Thior I, Foley BT, Gaolekwe S, Rybak N, Gaseitsiwe S, Vannberg F, Marlink R, Lee TH, Essex M.

J Virol. 2002 Jun;76(11):5435-51.

5.

Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design.

Novitsky V, Rybak N, McLane MF, Gilbert P, Chigwedere P, Klein I, Gaolekwe S, Chang SY, Peter T, Thior I, Ndung'u T, Vannberg F, Foley BT, Marlink R, Lee TH, Essex M.

J Virol. 2001 Oct;75(19):9210-28.

6.

Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design.

Novitsky V, Flores-Villanueva PO, Chigwedere P, Gaolekwe S, Bussman H, Sebetso G, Marlink R, Yunis EJ, Essex M.

Hum Immunol. 2001 Feb;62(2):146-56.

PMID:
11182225

Supplemental Content

Loading ...
Support Center